LRIG2 Antibody (C-term) Blocking peptide
€363.00
In stock
SKU
AC-BP13821b
Other Names:
Leucine-rich repeats and immunoglobulin-like domains protein 2, LIG-2, LRIG2, KIAA0806, LIG2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13821b was selected from the C-term region of LRIG2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: LRIG2
Gene ID: 9860
Primary Accession: O94898
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Leucine-rich repeats and immunoglobulin-like domains protein 2, LIG-2, LRIG2, KIAA0806, LIG2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13821b was selected from the C-term region of LRIG2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: LRIG2
Gene ID: 9860
Primary Accession: O94898
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review